{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-060245","form_type":"8-K","ticker":"INGN","cik":"0001294133","company_name":"Inogen Inc","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.551439+00:00","generated_at":"2026-06-08T13:51:50.359416+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Inogen Q3 revenue $84.0M, down 20.3% YoY; GAAP net loss $45.7M from $32.9M impairment","bullets":["Total revenue $84.0M vs $105.4M in Q3 2022, down 20.3% YoY.","GAAP net loss $45.7M vs $9.5M loss YoY; includes $32.9M non-cash impairment.","Adjusted net loss $8.5M vs $4.1M loss; Adjusted EBITDA loss $5.5M vs $1.2M loss.","Completed acquisition of Physio-Assist SAS, adding airway clearance portfolio.","Cash $138.0M, no debt; focusing on returning to revenue growth."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-060245","json":"https://secwatch.observer/filing/0000950170-23-060245.json","markdown":"https://secwatch.observer/filing/0000950170-23-060245.md","text":"https://secwatch.observer/filing/0000950170-23-060245.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1294133/000095017023060245/0000950170-23-060245-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1294133/000095017023060245/ingn-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T13:51:50.359416+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9d17287b06542230abb91ecfcd7b392312136571","claim":"Inogen Inc reported the quarter ended September 30, 2023 results: revenue $84.0 million, net income GAAP net loss of $45.7 million.","evidence_excerpt":"the homecare setting, today announced financial results for the quarter ended September 30, 2023. Third Quarter 2023 and Recent Business Highlights • Reported total revenue of $84.0 million, reflecting a decrease of 20.3% from the third quarter of 2022. • Completed acquisition of Physio-Assist SAS, expanding Inogen’s global respiratory care presence by addressing a","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1294133/000095017023060245/0000950170-23-060245-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$84.0 million"},{"label":"Net income","value":"GAAP net loss of $45.7 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}